Camber Spine receives FDA clearance for SPIRA-C Open Matrix Cervical Interbody device — 5 things to know

Written by Megan Wood | December 07, 2017 | Print  |

Camber Spine earned FDA clearance for its SPIRA-C Open Matrix Cervical Interbody device.

Here are five things to know:

 

1. The FDA's clearance represents Camber Spine's second in the SPIRA family.

 

2. SPIRA interbody implants are composed of titanium intended to improve fusion.

 

3. Camber Spine combined SPIRA Arch Technology with smart surfaces to foster cell proliferation and bone growth.

 

4. The SPIRA-C Open Matrix Cervical Interbody is intended for fusion at one or two contiguous levels from C3-C7 in patients with degenerative disc disease.

 

5. Camber Spine launched its SPIRA Open Matrix ALIF implant three months ago.

 

More articles on devices:
WishBone Medical appoints Jean-Pierre Capdevielle chief strategy officer: 3 notes
Smith & Nephew acquire Rotation Medical for $210M: 4 key points
FDA releases new guidance for 3-D printing medical devices: 5 things to know

 

 

© Copyright ASC COMMUNICATIONS 2018. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months